Saturday, 4 January 2020

DHA supplementation in pregancy


The role of DHA in the development of brain as well as in visual development is well established. Deficiency of (n-3) fatty acid may affect brain development at multiple levels, from membrane biogenesis, through gene expression, protection against oxidative stress, and altered neurotransmission. However, whether dietary DHA is important during human brain development is still an unresolved question.




Third trimester and the first two years of the life are important phases of rapid brain development known as “brain growth spurt”.During this period, polyunsaturated fatty acids of omega-3, mainly docosahexaenoic acid (DHA) plays a critical role in the growth and development of central nervous system of the developing baby. Additionally, DHA also confer beneficiary effect on mothers health during pregnancyIt is one of the most abundant constituents of brain and retina of eye and is involved in visual and neural function and neurotransmitter metabolism. Rapid accumulation of DHA takes place during the entire period of brain growth spurt. However, it is required in highest concentrations (somewhere around 50-70 mg/ day) during the third trimester. Tire accumulation of DHA into the central nervous system takes place until about 18 months of age and both maternal DHA intake as well as circulating DHA concentrations are important determinants of fetal blood concentrations of DHA.Insufficient supply of DHA during this development phase can result into serious complications of central nervous system.
As already described above, DHA is the most abundant structural fat in the brain and eyes but it is also present throughout the body. It is a long chain omega-3 fatty acid of 22 carbon atoms that represents about 97% and 93% of all omega-3 fatty acids in the brain and eyes, respectively. Natural sources of DHA are very limited and it is found in good quantity only in some foods, particularly fatty fish. Humans are also capable of synthesizing DHA from the essential fatty acid (EFA), a-linolenic acid (ALA). However, dietary inclusion is important for normal growth and development. Its deficiency can lead to a number of complications such as foetal alcohol syndrome, attention deficit hyperactivity disorder, cystic fibrosis, phenylketonuria, unipolar depression, aggressive hostility, and adrenoleukodystrophy. Reduction of DHA level in brain with aging is associated with cognitive decline and with the onset of sporadic Alzheimer disease.’
DHA is not only a key element of brain but it is also found in high abundance in heart. Epidemiological data positively link the consumption of fish, which are high source of DHA with reduced sudden death due to myocardial infarction. As much as 50% reduction in death has been observed with the consumption of 200 mg/day of DHA from fish. Furthermore, consumption of fish oil has also shown decreases in the proliferation of tumour cells and has a negative effect on inflammation associated with diseases like rheumatoid arthritis and asthma. The list of beneficial effect of DHA doesn’t end here. It also offers positive


effect on several other diseases such as hypertension, arthritis, atherosclerosis, depression, adult-onset diabetes mellitus, thrombosis, and some cancers.
DHA is essentially required for the healthy visual and mental development during pregnancy and its demand increases exponentially with the gestation age and it reaches its peak in the third trimester.5,7 The World Health Organization (WHO) and the Food and Agriculture Organization of the United Nations (FAO) recommends a daily intake of 100-300 mg of DFIA during pregnancy. A regular consumption of fish or omeag-3 fatty acid supplements during pregnancy results in increased circulating values of omega-3 polyunsaturated fatty acids in maternal blood, that is important for both fetal and maternal health.7 During the prenatal period, DHA is supplied to the fetus directly via placenta. Infants mainly gets DHA from breast milk however DHA requirement in infants can also be met though supplemented formula.
Studies on the effect of maternal DHA supplementation during the last trimester of pregnancy on their health and on the development of infants are limited and the results from these studies are mixed. Some studies have shown that maternal DHA supplementation have positive effects on neonates health especially in terms of cognitive development whereas some have shown no beneficial effect on infants development.
The role of DFIA in the development of brain as well as visual development is well established. Deficiency of (n-3) fatty acid may affect brain development at multiple levels, from membrane biogenesis, through gene expression, protection against oxidative stress, and altered neurotransmission. However, whether dietary DHA is important during human brain development is still an unresolved question. The accumulation of DHA in the nervous tissue of retina and brain is highest during the period of fetal development and early infancy, its availability during this time is crucial and its deficiency may have long term consequences for later brain function. Effect of maternal DHA supplementation continued till the last stages of pregnancy on the visual and/or cognitive
development after birth has been studied in few clinical trials. Malcolm el al., studied the effect of maternal docosahexaenoic acid (DHA) supplementation from week 15 of pregnancy until delivery in 100 women. The outcomes from the study showed no significant difference in maturity of the retina at one week of age. Furthermore, visual function assessed by visual evoked potential (VEP) to flash and pattern reversal stimuli also did not show any marked difference at birth and at 10 and 26 weeks of age, between neonates born to mothers supplemented with fish oil versus those born to mothers supplemented with high-olcic acid sunflower oil. However, visual development was significantly correlated with DHA status of the infants at birth, suggesting a possible association between the DHA status of infants at term and early postnatal development and function of the retina.9'" In a follow up study performed by Tofail et ah, the investigators evaluated the effect of maternal supplementation of fish oil (1.2 g DHA+1.8 g eicosapentaenoic acid/d) or soy bean oil (2.25 g linoleic acid+0.27 g ALA/d) during the last trimester of the pregnancy until delivery on cognitive outcomes of infants. Cognitive development was assessed once the infants were 10 months of age. The results demonstrated that DHA supplementation provided no added benefit over soy-oil in the cognitive development in infants. Both these studies demonstrated no significant effect of maternal n-3 long chain PUFA supplementation during pregnancy on visual function or cognitive development in the first year of life. However, these studies were having their own difference and limitation in the designs such as low dose and/or short duration of supplementation.9
In a study conducted by Helland et ah, the investigators studied the effect of supplementing mothers with either cod liver oil (1.2 g DHA/d) or corn oil (4.7 g LA)/d) from week 17-19 until the last trimester of pregnancy and continued for three months during lactation. Investigators reported no significant difference in electroencephalogram (EEC) maturity of the 2-day old neonates, 3-month old infants and for novelty preference at six and nine months of age among the two groups. However, at the age of 24, the children of mothers who received cod liver oil showed
developing baby but also for fortifying mothers own heath during pregnancy. Role of DHA has also been studied in conditions like prenatal stress, pregnancy induced hypertension that usually occurs during the third trimester of pregnancy. Additionally, there have been investigations that have evaluated the maternal DHA supplementation continued during the end stages of delivery on condition like postpartum depression.
As already mentioned, high accumulation of DHA in the foetus body takes place via placenta during the third trimester of pregnancy. This causes deficiency of DHA in mother's body. Without proper replenishment of DHA during this period, mother's body becomes susceptible to major depressive symptoms in the postpartum period. Results from a cross national study performed by Joseph R. Hibbeln on rates of postpartum depression among twenty-two countries showed that the lower the amount of DHA in the mother's blood, the higher is the chance that she will develop postpartum depression. These outcomes indicated that DHA supplementation especially during the later stages of pregnancy may be important in reducing major postpartum depressive symptoms. Keenan et al„ in their study evaluated the link between DHA supplementation and perceived stress and cortisol response to a stressor during pregnancy in a sample of African American women living in low-income environments. The enrolled women were supplemented with 450 rng/day of DHA or placebo from 16-21 weeks continued till the last trimester of pregnancy. Pregnant women in the active group receiving DHA had a lower incidence of reduced perceived stress and lower levels of stress hormones in the third trimester. These results suggest a positive effect of DHA supplementation in easing the effect of maternal stress during the third trimester.Next, studies have also suggested that DHA may beneficially influence pregnancy induced hypertension during the end stages of pregnancy. In a study performed by Gerrard et ah, the investigators demonstrated that inuit women with a diet rich in fish and sea mammals, potent source of omega-3 fatty acids, had a lower blood pressure at the end of pregnancy and a lower incidence of gestational hypertension compared to controls.15 Additionally, there is growing evidence that suggests DHA role in modulating insulin resistance that might prove to be beneficial in gestational diabetes. Furthermore, diet rich in omega-3 may be beneficial in reducing the risk of developing pre-eclampsia during pregnancy. Results from clinical studies suggest that the risk of developing pre-eclampsia is 7.5 times higher in mother with extremely low levels of omega-3 fatty acids than the mother whose levels of omega-3 are the highest. Studies have also indicated that a diet change in favor of omega-3 from omega-6 may reduce the risk of pre­eclampsia by 46%.
DHA is an important constituent of human body and is found in high abundance in the cells of brain and retina. DHA accumulated in high concentration during the third trimester of pregnancy that makes dietary intervention of DHA supplementation in mothers essential and the same is recommended by the WHO and the FAO. Although DHA role in the retina and brain development is well elucidated in literature, the studies evaluating the effect of DHA during the third trimester are limited. Studies on maternal supplementation continued till the end stages of pregnancy alone have not demonstrated any significant improvement on the visual or cognitive development in the first year of life of infants. However, DHA supplementation during pregnancy/lactation does offer some beneficial effect on the cognitive function. Furthermore, role of DHA supplementation in maternal health during third trimester has also been evaluated in few studies and the results do suggest a beneficial effect of DHA in conditions like prenatal stress, pregnancy induced hypertension that commonly occur during the end stages of pregnancy and also in postpartum depression.


No comments:

Post a Comment